Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-25-023498
Filing Date
2025-05-08
Accepted
2025-05-08 09:01:06
Documents
82
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q espr-20250331.htm   iXBRL 10-Q 921601
2 EX-10.1 firstsupplementalindentu.htm EX-10.1 9295
3 EX-31.1 espr-ex311x03312025.htm EX-31.1 11470
4 EX-31.2 espr-ex312x03312025.htm EX-31.2 11538
5 EX-32.1 espr-ex321x03312025.htm EX-32.1 8277
11 firstsupplementalindentu001.jpg GRAPHIC 50785
12 firstsupplementalindentu002.jpg GRAPHIC 230376
13 firstsupplementalindentu003.jpg GRAPHIC 289601
14 firstsupplementalindentu004.jpg GRAPHIC 60705
15 firstsupplementalindentu005.jpg GRAPHIC 50258
16 firstsupplementalindentu006.jpg GRAPHIC 49079
  Complete submission text file 0001628280-25-023498.txt   7762133

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT espr-20250331.xsd EX-101.SCH 62228
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT espr-20250331_cal.xml EX-101.CAL 56661
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT espr-20250331_def.xml EX-101.DEF 292949
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT espr-20250331_lab.xml EX-101.LAB 734286
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT espr-20250331_pre.xml EX-101.PRE 497655
85 EXTRACTED XBRL INSTANCE DOCUMENT espr-20250331_htm.xml XML 770144
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35986 | Film No.: 25924126
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)